Renal Function and Outcome From Coronary Artery Bypass Grafting

Author:

Hillis Graham S.1,Croal Bernie L.1,Buchan Keith G.1,El-Shafei Hussein1,Gibson George1,Jeffrey Robert R.1,Millar Colin G.M.1,Prescott Gordon J.1,Cuthbertson Brian H.1

Affiliation:

1. From the Departments of Cardiology (G.S.H.), Cardiac Surgery (K.G.B., H.E.S., G.G., R.R.J.), Clinical Biochemistry (B.L.C.), Nephrology (C.G.M.M.), and Public Health (G.J.P.), and Health Services Research Unit (B.H.C.), University of Aberdeen and Aberdeen Royal Infirmary, Aberdeen UK.

Abstract

Background— Severe renal dysfunction is associated with a worse outcome after coronary artery bypass graft surgery (CABG). Less is known about the effects of milder degrees of renal impairment, and previous studies have relied on levels of serum creatinine, an insensitive indicator of renal function. Recent studies have suggested that estimated glomerular filtration rate (eGFR) is a more discriminatory measure. However, data on the utility of eGFR in predicting outcome from CABG are limited. Methods and Results— We studied 2067 consecutive patients undergoing CABG. Demographic and clinical data were collected preoperatively, and patients were followed up a median of 2.3 years after surgery. Estimated GFR was calculated from the Modification of Diet in Renal Disease equation. The primary outcome was all-cause mortality. Mean±SD eGFR was 57.9±17.6 mL/min per 1.73 m 2 in the 158 patients who died during follow-up compared with 64.7±13.8 mL/min per 1.73 m 2 in survivors (hazard ratio [HR], 0.71 per 10 mL/min per 1.73 m 2 ; 95% CI, 0.64 to 0.80; P <0.001). Estimated GFR was an independent predictor of mortality in both models with other individual univariable predictors (HR, 0.80 per 10 mL/min per 1.73 m 2 ; 95% CI, 0.72 to 0.89; P <0.001) and the European system for cardiac operative risk evaluation (HR, 0.88 per 10 mL/min per 1.73 m 2 ; 95% CI, 0.78 to 0.98; P =0.02). Conclusions— Estimated GFR is a powerful and independent predictor of mortality after CABG.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3